DiscoverMedTech ON AIRThe Lifeblood of Europe’s Medical Technology Sector: Collaborative R&I, Mark Lloyd Davies
The Lifeblood of Europe’s Medical Technology Sector: Collaborative R&I, Mark Lloyd Davies

The Lifeblood of Europe’s Medical Technology Sector: Collaborative R&I, Mark Lloyd Davies

Update: 2024-02-29
Share

Description

How do Europe’s unique R&I environment and opportunities provide fertile ground for our sector’s life changing innovations?

In the second episode of MedTech ON AIR, we welcome Johnson & Johnson’s Global Head of Strategic Partnerships and Resource Group (SPRG), Mark Lloyd Davies.

Listen in as Mark as shares his insights from his longstanding experience working in collaborative research and innovation in Europe, and what makes the EU environment unique. We delve into the potential of public private partnerships, practical advice on participating in the Innovative Health Initiative, and reflections on a new multistakeholder project.

Curious to learn more about the red thread driving the medical technology sector? Learn more in the MedTech Europe Manifesto: https://bit.ly/49zo9W2
Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

The Lifeblood of Europe’s Medical Technology Sector: Collaborative R&I, Mark Lloyd Davies

The Lifeblood of Europe’s Medical Technology Sector: Collaborative R&I, Mark Lloyd Davies

MedTech Europe